Sort
261,768 grants matching “gene therapy”
Molecular diagnosis and outcome prediction in lymphoma
$936,810Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Oncogenic mechanisms and molecular targets in lymphoma
$936,810Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
RNA interference-based screens for molecular targets in cancer
$936,810Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Clinical production of viral vectors for cancer gene therapy
$936,788Steven Feldman · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
WU-SN-TMC Bio-Analysis Core
$936,769Feng Chen · Washington University · U54 · FY2021 · AG
Neonatal Porcine Islet Xenografts for the Treatment of Type 1 Diabetes
$936,759Allan D. Kirk · Duke University · U01 · FY2019 · AI
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$936,750Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Chemical Genomics Paradigm for Epigenetic Regulation
$936,720Ming-Ming Zhou · Icahn School Of Medicine At Mount Sinai · R01 · FY2008 · HG
Computational Tools For Bioinformatics And Genome Analysis
$936,720John I Powell · Center For Information Technology · ZIA · FY2013 · CT
Interdepartmental Biotechnology Training Program
$936,676Karl D Wittrup · Massachusetts Institute Of Technology · T32 · FY2006 · GM
Defining New Human Immunodeficiency and Immunodysregulation Disorders
$936,668Helen Su · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Improved Chimeric Antigen Receptor Therapies B-cell Malignancies
$936,552James Kochenderfer · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Tissue mechanics reprograms the tissue to malignancy and metastasis
$936,361Valerie Marie Weaver · University Of California, San Francisco · R35 · FY2023 · CA
Mosaic: post-zygotic mutations in vascular malformations
$936,355James T Bennett · Seattle Children'S Hospital · R01 · FY2020 · HL
Integrated, Individualized, Intelligent Prescribing (I3P)
$936,331Josh F. Peterson · Vanderbilt University Medical Center · U01 · FY2017 · HG
ASPirin in Reducing Events in the Elderly
$936,324Anne M Murray · Hennepin Healthcare Research Institute · U01 · FY2017 · AG
Targeting the Epigenome for Lung Cancer Therapy
$936,250David Schrump · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
Elucidation and targeting of paracrine cascades in PDAC
$936,242Kenneth P Olive · Columbia University Health Sciences · U01 · FY2024 · CA
Development of Ciclopirox Prodrug as a Novel Systemic Treatment for High-Risk Non-Muscle Invasive Bladder Cancer
$936,240William Mc Culloch · Ciclomed, Llc · R44 · FY2020 · CA
ASPirin in Reducing Events in the Elderly
$936,165Richard H Grimm · Hennepin Healthcare Research Institute · U01 · FY2012 · AG
PROTECT - Harnessing PROTEin degradation for Advanced Childhood Tumors
$936,142Nathanael Schiander Gray · Stanford University · OT2 · FY2024 · CA
Ramipril treatment of claudication: oxidative damage and muscle fibrosis
$936,115Iraklis Ilias Pipinos · University Of Nebraska Medical Center · R01 · FY2016 · AG
BCC for Prostate Cancer: Discovery and Translation of Biomarkers for Clinical Unmet Needs
$936,098Daniel W Chan · Johns Hopkins University · U2C · FY2024 · CA
Novel Model for HIV Latency in Primary Memory T Cells
$936,050Eric M Verdin · J. David Gladstone Institutes · DP1 · FY2014 · DA
Novel macrophage-tropic transmitted/founder SHIV model of CNS persistence to evaluate CRISPR/Cas9 gene editing
$936,026Katharine June Bar · University Of Pennsylvania · R01 · FY2023 · MH